Newsroom | 28077 results
Sorted by: Latest
-
LGBTQI+ Leaders Gather in Los Angeles to Support the Rights of All Americans to Live Their Lives Freely and Fairly
LOS ANGELES--(BUSINESS WIRE)--LGBTQI+ Leaders Gather in Los Angeles to Support the Rights of All Americans to Live Their Lives Freely and Fairly...
-
P&G Declares Quarterly Dividend, January 2026
CINCINNATI--(BUSINESS WIRE)--The Board of Directors of The Procter & Gamble Company (NYSE:PG) declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2026 to Common Stock shareowners of record at the close of business on January 23, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareowners of record at the start of business o...
-
FDA Files Rejoni’s Juveena® Hydrogel System PMA for the Prevention of Intrauterine Adhesions
BEDFORD, Mass.--(BUSINESS WIRE)--Rejoni, Inc., a clinical-stage company focused on uterine health, today announced that the U.S. Food and Drug Administration (FDA) has completed its filing review and formally filed the Premarket Approval (PMA) application for the Juveena Hydrogel System. In its filing notification, FDA stated that the submission contains the information needed to proceed with substantive review. The Juveena Hydrogel System is designed as a temporary spacer to help prevent the f...
-
hol+ debuts as the first full service, comprehensive holistic health experience addressing personal and family health
ATLANTA--(BUSINESS WIRE)--Dr. Taz Bhatia, a leading expert in modernized holistic medicine, integrating traditional healing with contemporary medical advancements, has reimagined the future of health with the launch of hol+. This new functional medical home combines the best of eastern and western medicine to create a one stop shop for primary and consultative care, utilizing a holistic approach. hol+, founded by triple board-certified physician and integrative medicine pioneer Dr. Taz Bhatia,...
-
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening...
-
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for a Hot Flash’ campaign, which speaks to women with moderate to severe hot flashes due to menopause. The campaign encourages women to have an open and honest conversation with their healthcare provider about their hot flash experiences and learn about treatment options, including Lynkuet® (elinzanetant) 60mg capsules, a hormone-free prescri...
-
Kaplan and HerMD Founder Dr. Somi Javaid Hold Webinar to Spotlight Menopause and Critical Issues in Women’s Midlife Health
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Kaplan to host free webinar on menopause on January 27 at 1 PM ET with Dr. Somi Javaid, board-certified OB/GYN, surgeon, and founder of HerMD....
-
Positive Development Secures $45 Million Growth Facility to Expand Access to Developmental Therapy and Autism Diagnostics Nationwide
MCLEAN, Va.--(BUSINESS WIRE)--Top developmental therapy provider for autistic youth, Positive Development closes new $45M debt facility to support its next phase of growth....
-
Humana Expands Cancer Care for Medicare Advantage Members Through Atlas Oncology Partnership
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana expands cancer care for eligible Medicare Advantage members in Tennessee and Mississippi through Atlas Oncology partnership....
-
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an advancement in molecular residual disease (MRD)-based risk stratification that is expected to extend the company’s leadership in oncology. The new multi-modal model will integrate longitudinal ctDNA and clinical data with digital pathology imaging and tumor sequencing data, to enhance the Signatera™ MRD assessment. Signatera has transformed can...